纳指生物科技ETF(513290)

动态评分: 5.70分

投资组合

报告日期 名称 比例
2024-06-30 Anavex Life Sciences Corp 0.04%
2024-06-30 Cabaletta Bio Inc 0.04%
2024-06-30 AC Immune SA 0.04%
2024-06-30 Fulcrum Therapeutics Inc 0.04%
2024-06-30 Precigen Inc 0.04%
2024-06-30 Verve Therapeutics Inc 0.04%
2024-06-30 Pacific Biosciences of California Inc 0.04%
2024-06-30 美国辉宝 0.04%
2024-06-30 Editas Medicine Inc 0.04%
2024-06-30 Theravance Biopharma Inc 0.04%
2024-06-30 Lyell Immunopharma Inc 0.04%
2024-06-30 GRAIL Inc 0.04%
2024-06-30 Voyager Therapeutics Inc 0.04%
2024-06-30 MaxCyte Inc 0.04%
2024-06-30 MacroGenics Inc 0.03%
2024-06-30 Atea Pharmaceuticals Inc 0.03%
2024-06-30 Vanda Pharmaceuticals Inc 0.03%
2024-06-30 Exscientia plc ADR 0.03%
2024-06-30 Xeris制药 0.03%
2024-06-30 阿玛琳 0.03%

投资模拟

公告&资料